Menu Close
Image of people around a table, in discussion
12th Asia Regulatory Conference

Evolving landscapes

Asia’s role in driving a more efficient, innovative and patient-centric regulatory environment

03 - 06 December 2024
Online 07:30 - 10:30 CET / 17:30 - 20:30 AEDT
Online 07:30 - 10:30 CET / 17:30 - 20:30 AEDT

The transformative power
of regulatory collaboration

For over a decade, the Asia Regulatory Conference has served as a platform for meaningful and solutions-oriented exchanges among regulatory authorities, academia and experts from the pharmaceutical industry on timely topics to evolve the regulatory landscape in the region.

The latest edition, held on 3-6 December 2024, explored how regulatory reliance and work-sharing between national regulatory authorities can support pharmaceutical innovation and address regional health challenges.

View the program and resources See the experts

Key focus areas

Enhancing innovation through collaborative regulatory frameworks: Best practices for regulatory reliance in Asia and their global impact.

E-labelling as a pathway to a future Universal Label: Bridging across regulatory systems, promote data-sharing, and streamline access to product information across regions.

Pilots and capability-building initiatives: Strategies to address regional health challenges through capability building and work-sharing between national regulatory authorities.

Standard harmonization: Addressing the challenges and opportunities in the global regulatory landscape, through the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Event partner

Medicines Australia

Medicines Australia leads the research-based pharmaceutical industry of Australia. Our members discover, develop and manufacture the medicines that are the foundation of a healthy and prosperous society, including prescription pharmaceutical products, biotherapeutic products and vaccines.

Visit website